On average, our clients lose 18% weight loss sustained. Learn how it works.
Are you seeking help on your weight loss journey and searching for an effective solution? Peptide therapy, particularly with injectable peptides, could be what you’ve been looking for.
Our treatment program is designed to boost your body's metabolic rate, which
determines how much energy your body consumes. This is crucial for maintaining a
healthy weight over time. By using our medications, we can increase your metabolic
rate and promote continuous calorie burning throughout the day.
Shedding pounds can kickstart your energy levels and encourage healthy behaviors like
boosting physical activity. Our program not only aids in weight loss but also helps you
adopt a more active lifestyle.
Losing weight can revitalize your energy levels and promote healthy habits like
increasing physical activity. Our program not only facilitates weight loss but also
empowers you to embrace a more active lifestyle.
Our treatment plan can also enhance your heart health. The use of GLP-1 medications
may decrease your risk of heart disease and reduce blood pressure levels.
Tirzepatide is a medication primarily used for type 2 diabetes that also aids in weight loss by decreasing appetite and slowing digestion.
In clinical trials, tirzepatide led to an average weight reduction of 19.5% to 20.9% in adults with obesity over 72 weeks.
Yes, tirzepatide can be used for weight loss in individuals without diabetes.
It mimics hormones that reduce appetite and slow stomach emptying, leading to a feeling of fullness.
Side effects may include nausea, vomiting, diarrhea, or constipation, which usually resolve over time.
Significant weight loss can be observed over several weeks to months, with optimal results seen after 72 weeks.
Yes, it is approved for weight loss in adults with obesity or overweight with related health issues.
A balanced diet and regular exercise are recommended to maximize weight loss.
The recommended dosage for tirzepatide begins with an initial dose of 2.5 mg administered subcutaneously once a week. After four weeks, the dosage should be increased to 5 mg weekly. If additional glycemic control is needed, the dose can be further increased in 2.5 mg increments after at least four weeks on the current dose, with a maximum dose of 15 mg per week. The dosage may be adjusted based on individual response and tolerability.